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Conclusions: Lower knee conﬁdence was associated with worse physi-
cal function in persons with or at risk for knee OA. This relationship was
partially attenuated after adjusting for pain severity, but not after adjusting
for other factors. These results introduce the possibility that conﬁdence
may play a pivotal role in the path to function decline; awareness of this
and attention to it may help to prevent poor outcome.
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Purpose: Overweight is a major risk factor for the development and
progression of knee osteoarthritis (OA) and weight loss is recommended
by OARSI as part of the non-pharmacologic management of patients
with knee OA. This analysis examined the relationship between weight
change and change in self-reported symptoms and function and physical
performance in adults with symptomatic radiographic knee OA over one
year.
Methods: Data for these analyses were obtained from the Osteoarthri-
tis Initiative (OAI) database, which is available for public access at
<http://www.oai.ucsf.edu/>. Speciﬁcally, we examined data from the base-
line and 12-month follow-up visits for 711 subjects with symptomatic
radiographic knee OA enrolled in the Progression subcohort. All subjects
completed the Western Ontario McMaster Osteoarthritis Index (WOMAC)
and Knee Osteoarthritis Outcome Scale (KOOS) at both visits. Weight
was measured with a balance beam scale, height was measured with a
stadiometer and physical performance was measured with a timed 20-
meter walk. Names and dosage of medications and supplements were
recorded at both clinic visits by trained personnel. Correlations between
change in weight and outcomes were examined in unadjusted and
multiple variable adjusted models using generalized estimating equations
to control for the correlation between knees in subjects with more than
one involved knee at baseline. In addition, subjects were categorized
into tertiles based on weight change and the change in outcomes was
examined across tertiles using analysis of variance.






WOMAC Pain Scale −0.031 −0.032
WOMAC Function Scale 0.033 0.029
WOMAC Total 0.021 0.019
KOOS Symptom Scale 0.004 0.003
KOOS Pain Scale −0.001 0.002
KOOS Function Scale −0.026 −0.029
KOOS Quality of Life −0.025 −0.023
20-meter Walk Speed −0.099* −0.098*
*P< 0.01
Table 2: Change in Weight and Selected Outcomes (mean [SD]) by Tertile of Weight Change






Weight change, kg 3.36 (2.9) 0.14 (0.6) −4.01 (3.9)
Change in WOMAC Pain −0.87 (3.1) −0.42 (3.0) −0.48 (2.9)
Change in WOMAC Function −1.87 (9.1) −2.09 (9.3) −1.74 (9.6)
Change in WOMAC Stiffness −0.24 (1.6) −0.42 (1.7) −0.11 (1.5)
Change in WOMAC Total Score −3.06 (12.3) −2.92 (12.3) −2.36 (12.6)
Change in KOOS Pain 4.65 (14.9) 3.52 (15.4) 3.29 (14.3)
Change in KOOS Function 5.19 (22.4) 1.66 (21.4) 3.57 (16.0)
Change in KOOS Symptoms 2.55 (12.6) 4.23 (14.1) 1.03 (13.4)
Change in KOOS VAS Symptoms −0.55 (2.6) −0.27 (2.5) −0.27 (2.0)
Change in KOOS Quality of Life 4.00 (17.3) 2.86 (17.4) 4.27 (15.8)
Change in KOOS VAS Quality of Life −0.40 (2.1) 0.23 (2.1) −0.33 (2.0)
Change in Walking Speed, m/sec −0.02 (0.16) −0.01 (0.15) 0.01 (0.14)
Results: At entry, the 711 subjects had a mean (SD) age of 61.8 (9.4)
years; 422 (59.4%) were women and 582 (81.9%) were white. The mean
weight, height and body mass index (BMI) were 85.0 (16.7) kg, 1.68 (0.09)
meters and 30.0 (4.9) kg/m2, respectively. One-third had bilateral symp-
tomatic radiographic knee OA. Over an average of 12 months, the mean
(SD) weight change was −0.20 (4.07) kg: mean (SD) weight change was
−4.01 (3.9), 0.14 (0.6) and 3.36 (2.9) kg for the tertile that lost weight, had
stable weight and gained weight, respectively. In unadjusted analyses,
the only signiﬁcant correlation of weight change with symptomatic and
functional outcomes was with the 20-meter walking speed: R=−0.099,
P< 0.01. This correlation remained signiﬁcant after adjustment for age,
gender, race, baseline BMI and use of analgesic and/or antiinﬂammatory
medications at both visits (see Table 1). Analyses comparing change in
symptomatic and functional outcomes across tertiles, failed to demon-
strate signiﬁcant trends across groups based on weight change (see
Table 2).
Conclusions: These data, from a subset of participants with symptomatic
radiographic knee OA in the OAI, demonstrate a signiﬁcant inverse corre-
lation between weight change and change in walking speed, a measure
of physical performance, but fail to demonstrate signiﬁcant correlations
between weight change and changes in self-reported symptoms and
function. Further analyses will explore the relationship between weight
change and change in structural outcomes assessed with ﬁxed ﬂexion
knee radiographs and magnetic resonance imaging.
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Purpose: In the study of osteoarthritis (OA) and its impact on society it is
important to have up-to-date prevalence estimates. Due to the Swedish
health care system, where all residents are insured and the computerized
registration of all clinic visits including diagnosis as given by the physician,
we can obtain information on disease occurance in a intrigue fashion.
Thus, our objective was to determine the prevalence knee and hip OA in
southern Sweden.
Methods: In Sweden all residents are insured and entitled to health
care. By law all in- and outpatient health care provided to residents is
prospectively registered by the individual’s unique identiﬁcation number,
which also provides information on date of birth and sex. Other types of
data that are registered include date of visit, the health care provider, and
diagnosis code according to the International Classiﬁcation of Diseases
and Related Health Problems (ICD-10) system. We identiﬁed all residents
having received an ICD-10 diagnosis code of knee OA (M17) or hip
OA (M16) at a clinic visit to a physician between January 1, 2000 and
December 31, 2006 in the southernmost region of Sweden. Estimates
of point prevalence were obtained by cross-referencing personal identi-
ﬁcation numbers with those from the National Population Registry (total
population in the region = 1,184,500). Individuals that have had a clinic
visit in the period with a hip or knee OA diagnosis code that were
deceased or had relocated out of the region by December 31, 2006
(no longer in the National Population Registry) were excluded from the
nominator. We deﬁned the individuals’ age by their age 2006.
Results: The point prevalence of diagnosed knee and hip OA among
residents of southern Sweden across all ages was 2.02% (95%CI 2.00,
2.05) and 1.08% (95%CI 1.07, 1.10), respectively. The peak prevalence
of diagnosed knee and hip OA in women and men, respectively, was
found in individuals aged 74 to 85 years (table 1, ﬁgure 1).
Conclusions: These OA prevalence ﬁgures derived from actual health
care seeking individuals demonstrate the potential burden of the disease
on society. The age- and sex-speciﬁc characteristics of the estimates are
typical of those patterns previously reported supporting external validity
of these registry data. Importantly, these ﬁgures should be considered
conservative estimates of the “true” OA prevalence. Remembering, they
only reﬂect individuals symptomatic enough to seek health care and get
an OA diagnosis. The estimates do not include individuals that do not
seek health care, e.g., they self-medicate or individuals that do seek
health care but only received an unspeciﬁc ICD-10 code for their clinic
visit(s).
Table 1: Prevalence of knee and hip osteoarthritis (OA) in men and women aged 75 to 84 years
Location Prevalence (95%CI)
Men Women
Knee OA 6.5% (6.2, 6.8) 9.1% (8.8, 9.4)
Hip OA 5.2% (4.9, 5.4) 5.6% (5.4, 5.8)
Poster Presentations – Epidemiology & Health Services Research S137
Figure 1: Age and sex-stratiﬁed prevalence estimates of diagnosed knee
and hip osteoarthritis in southern Sweden by Dec 31 2006
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Purpose: Knee osteoarthritis is the most common cause of painful knee
from age 50. It is very frequent in the Spanish population. According to
the EPISER study, performed by the Spanish Society of Rheumatology,
29% of the Spanish population over age 60 showed symptomatic knee
osteoarthritis. The aim of this study was to assess the consumption
of health care and Social Security resources by a group of patients
diagnosed with knee osteoarthritis in an urban Primary Care Clinic in
La Corun˜a (Spain).
Methods: A transversal descriptive study was performed, which included
patients over age 25 and diagnosed with knee osteoarthritis. The total
number of patients was 200. Direct medical costs were studied: total
number of Primary Care consults, lab, x-rays and sick leave costs. Direct
medical costs were calculated according to the economic value assigned
to health care in D.O.G. (Diario Oﬁcial de Galicia, Law 159/2005, June 2)
and lab tests fees of the Spanish Society of Clinical Biopathology. The
labor cost per worker were estimated from published sources (National
Statistical Institute).
Results: According to SERGAS reference fees, the Primary Care cost
per consult is 26.50€. Considering that the total number of consults was
1,003, the total annual cost is 26,579€ (133€ per patient per year). The
cost of a basic lab test is 13.44€. The number of lab tests performed in
one year was 285, so the total cost generated is 3,830€ (19€ per patient
per year). 188 patients were referred for radiology, and three x-rays were
performed per patient: one AP on knees and lateral x-rays on each knee.
The total nu mber of x-rays was 564. The reference cost per x-ray is
27.58€. The total annual cost is 15,555€ (78€ per patient per year). The
number of sick leave days was 2,675, which generated a total cost of
119,037€. The annual sick leave cost per patient generated by the 57
working-age patients (28.5% over 200 between ages 25 and 65) would
be 2,088€.
Conclusions: Knee osteoarthritis is a major cause of utilisation of health
care resources and sick leave in our clinic. The sick leave cost is more
than twice the direct medical costs in Primary Care. The cost per patient
per year is 825€, this amount leaving aside pharmaceutical costs.
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Purpose: The same degree of radiographic knee osteoarthritis can be
asymptomatic in one individual or be associated with clinically signiﬁcant
pain and disability in another. A better understanding of the predictors
of frequent knee symptoms associated with radiographic tibio-femoral
osteoarthritis (TF-ROA) is needed to develop better prevention and treat-
ment strategies.
Objective: To evaluate the one-year predictors of symptomatic TF-ROA
in knees without frequent symptoms (FKSx) at baseline.
Methods: We studied 695 men and women between the ages of 45−79
enrolled in the Osteoarthritis Initiative out of 2686 who had 12 months of
follow-up and had TF-ROA in at least one knee and were without FKSx in
the affected knee at baseline. Data are from the OAI public use datasets
0.2.1 and 1.1.2. Bilateral PA ﬁxed ﬂexion knee x-rays were obtained in all
subjects at entry. Trained readers determined the presence of TF-ROA
and its severity using a modiﬁed Kellgren-Lawrence scoring system. FKSx
were deﬁned as pain, aching or stiffness on most days of any month
during the past year for each knee individually. Adjusted Odds ratios
(aOR) for development of FKSx at one year among those free of FKSx
at entry were calculated using generalized estimating equations (GEE) to
control for clustering of knees within subjects after adjusting for potential
confounders using backward selection with P< 0.10. The multivariate
analysis adjusted for the following confounders determined at the baseline
interview and examination: age, right or left knee, progression or incident
cohort, and clinical center plus the predictor variable listed in the table
below.
Results: Of the 896 knees with TF-ROA at baseline (mean K-L
score = 2.6, SD=0.61) and without FKSx, 511 developed FKSx at year
one and 385 remained without FKSx. The multivariate aOR’s for the
development of FKSx at one year with baseline TF-ROA are summarized
in the table below:
Exposure aOR 95%CI
WOMAC – Total 1.08 1.05−1.11
Ever Smoked 0.72 0.52−0.99
Right Handedness 2.13 1.09−4.16
Valgus (>0 degrees) 1.41 0.99−2.00
Knee injury 1.67 1.11−2.52
Knee surgery from injury 2.69 1.40−5.16
Race, gender, baseline severity of TF-ROA, BMI, knee ﬂexor and extensor
strength, 200 meter walk, medication use, degree of physical activity,
depression were not associated with development of FKSx at one year.
WOMAC stiffness, pain and disability sub-scales each independently
predicted FKSx at one year but were collinear preventing multivariate
analysis.
Conclusions: Right hand dominance, history of signiﬁcant knee injury
and knee surgery as the result of knee injury as well as baseline pain and
disability (WOMAC-total) were associated with development of frequent
knee symptoms at one year in those with radiographic tibio-femoral knee
osteoarthritis and without frequent knee symptoms at baseline in a large
cohort. Future research into the mechanism by which these predictors
are associated with increased symptoms is warranted.
